Proto Labs, Inc. (PRLB)

NYSE Currently up 1.33 (+1.54%) in today's trading session

1 member of Congress has disclosed 1 trade in Proto Labs, Inc. (PRLB) via STOCK Act filings. The most recent disclosure was a sale by Lois Frankel on 25 April 2014. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Proto Labs, Inc. is currently trading at $87.75, positioned at 89% of its 52-week range ($45.10 – $93.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$87.75
24h Change
+1.33 (+1.54%)
52 Week Range
$45.10$93.00
View on NASDAQ

Proto Labs, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for PRLB

Select to highlight on chart
1 transactions
Compliance: 100%
Lois Frankel25 Apr 201421 May 2014SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$2.09B

Volume

453.61K

Beta

1.42

P/E Ratio

47.18

Fundamentals

EPS

$1.86

Div. Yield

-

Open

$86.99

Day Range

$84.30 – $87.78

Company Information

Sector
Industrials
Industry
Manufacturing - Miscellaneous
Exchange
NYSE · USD
Country
US
CEO
Suresh Krishna
IPO Date
2012-02-24

Proto Labs, Inc., together with its affiliated companies, functions as a global, e-commerce-driven digital manufacturer, specializing in the rapid creation of custom prototypes and on-demand production components. The firm provides a comprehensive su...

Earnings

Next Report

Q3 2026

30 Oct

EPS Est.

$0.60

Rev. Est.

$149M

Days Until

39

Recent Quarters

Q2 202631 Jul
EPS$0.60
Beat 13.2%
Q1 20261 May
EPS$0.54
Beat 35.0%
Q4 20256 Feb
EPS$0.44
Beat 25.7%
Q3 202531 Oct
EPS$0.47
Beat 20.5%
Q2 202531 Jul
EPS$0.41
Beat 24.2%
Q1 20252 May
EPS$0.33
Beat 17.9%
Q4 20247 Feb
EPS$0.38
Beat 18.8%
Q3 20241 Nov
EPS$0.47
Beat 42.4%
Q2 20242 Aug
EPS$0.38
Beat 11.8%
Q1 20243 May
EPS$0.40
Beat 33.3%
Q4 20239 Feb
EPS$0.46
Beat 53.3%
Q3 20233 Nov
EPS$0.51
Beat 70.0%
Q2 20234 Aug
EPS$0.33
Beat 10.0%
Q1 20235 May
EPS$0.30
Beat 36.4%
Q4 202210 Feb
EPS$0.26
Beat 23.8%
Q3 20224 Nov
EPS$0.40
Beat 5.3%
Q2 20225 Aug
EPS$0.46
Beat 21.1%
Q1 20226 May
EPS$0.38
Beat 35.7%
Q4 202111 Feb
EPS$0.41
Beat 51.9%
Q3 202128 Oct
EPS$0.35
Miss 12.5%
Q2 202129 Jul
EPS$0.39
Miss 11.4%
Q1 20216 May
EPS$0.40
Beat 8.1%
Q4 202012 Feb
EPS$0.50
Beat 4.2%
Q3 202029 Oct
EPS$0.67
Beat 28.9%
Q2 202028 Jul
EPS$0.59
Beat 63.9%
Q1 202030 Apr
EPS$0.61
Beat 60.5%
Q4 20196 Feb
EPS$0.63
Beat 0.0%
Q3 201924 Oct
EPS$0.76
Beat 2.7%
Q2 201925 Jul
EPS$0.71
Beat 1.4%
Q1 201925 Apr
EPS$0.69
Beat 0.0%
Q4 20187 Feb
EPS$0.74
Miss 7.5%
Q3 201825 Oct
EPS$0.86
Beat 16.2%
Q2 201826 Jul
EPS$0.73
Beat 1.4%
Q1 201826 Apr
EPS$0.71
Beat 4.4%
Q4 20178 Feb
EPS$0.58
Beat 3.6%
Q3 201726 Oct
EPS$0.56
Beat 7.7%
Q2 201727 Jul
EPS$0.49
Beat 2.1%
Q1 201727 Apr
EPS$0.51
Beat 13.3%
Q4 20169 Feb
EPS$0.41
Beat 5.1%
Q3 201627 Oct
EPS$0.51
Beat 15.9%
Q2 201628 Jul
EPS$0.45
Miss 6.3%
Q1 201628 Apr
EPS$0.44
Miss 4.3%
Q4 20154 Feb
EPS$0.50
Beat 6.4%
Q3 201522 Oct
EPS$0.52
Miss 1.9%
Q2 201523 Jul
EPS$0.50
Beat 4.2%
Q1 201523 Apr
EPS$0.45
Beat 0.0%
Q4 20145 Feb
EPS$0.43
Beat 2.4%
Q3 201423 Oct
EPS$0.44
Miss 4.3%
Q2 201424 Jul
EPS$0.45
Beat 7.1%
Q1 20141 May
EPS$0.41
Beat 5.1%
Q4 201311 Feb
EPS$0.39
Beat 5.4%
Q3 201331 Oct
EPS$0.37
Beat 2.8%
Q2 20131 Aug
EPS$0.36
Beat 2.9%
Q1 201325 Apr
EPS$0.35
Beat 12.9%
Q4 201213 Feb
EPS$0.31
Beat 19.2%
Q3 201225 Oct
EPS$0.29
Beat 26.1%
Q2 201224 Jul
EPS$0.23
Beat 15.0%
Q1 20124 May
EPS$0.22
Q1 20123 May
EPS$0.24
Beat 14.3%
Q2 201130 Sept
EPS$0.40
Q1 201130 Jun
EPS$0.34
Q4 201031 Mar
EPS$0.37
Q3 201031 Dec
EPS$0.19
Q2 201030 Sept
EPS$0.18
Q1 201030 Jun
EPS$0.14
Q4 200931 Mar
EPS$0.08

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about PRLB

Which members of Congress have traded PRLB?
1 member of Congress has disclosed 1 trade in Proto Labs, Inc. (PRLB) under the STOCK Act: Lois Frankel.
When was PRLB most recently disclosed by Congress?
The most recent PRLB disclosure was a sale by Lois Frankel on 25 April 2014.
What is the total disclosed congressional trading volume for PRLB?
Members of Congress have disclosed approximately $8K in PRLB sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in PRLB?
This PRLB page updates as soon as new STOCK Act disclosures are filed for Proto Labs, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.